Mind Medicine To Raise Further $19.5 Million In Bought Deal
Mind Medicine (NEO: MMED) this morning announced that it is conducting yet another round of financing, after having raised $92.1
Read more
Psychedelics
Pure Extracts Applies For Dealers License With Health Canada
Pure Extracts (CSE: PULL) continues to focus on the development of its mushroom-related operations in addition to cannabis. The company
Read more
Mind Cure Health Begins Manufacturing Synthetic Ibogaine
Mind Cure Health (CSE: MCUR) this morning announced that it has begun the first stage of the manufacture of pharmaceutical
Read more
Psyched Wellness Completes Maximum Tolerated Dosage Study For Amanita Muscaria Extract AME-1
Psyched Wellness (CSE: PSYC) this morning issued a brief press release related to the ongoing pre-clinical trial of its muscimol
Read more
PharmaTher Collaborates For Research On Psychedelic Microdosing Tech
PharmaTher Inc (CSE: PHRM) this morning announced that it will be conducting further research related to psychedelics. The company this
Read more
Mind Cure Health Appoints Rob Hill To Board Of Directors
Mind Cure Health (CSE: MCUR) this morning announced the appointment of Rob Hill to the firms board of directors. The
Read more
MindMed Acquires HealthMode For $41.6 Million
MindMed (NEO: MMED) this morning announced that it will be acquiring that of HealthMode in a largely stock-based transaction. HealthMode
Read more
Mind Cure Launches Product Sales Division
Mind Cure Health (CSE: MCUR) continued its constant roll of news this week, announcing this morning that it has launched
Read more
Psyched Wellness Raises $6.6 Million In Bought Deal Financing
Psyched Wellness (CSE: PSYC) has closed its previously announced private placement. The company managed to raise an impressive $6.6 million
Read more
PharmaTher, Revive, Complete Psilocybin Intellectual Property Transaction
PharmaTher (CSE: PHRM) has seen the completion of the sale of its psilocybin program to that of Revive Therapeutics (CSE:
Read more